Details of the Drug

General Information of Drug (ID: DM4DP70)

Drug Name

SAP-001

Indication

Disease Entry	ICD 11	Status	REF
Gout	FA25	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Glucose transporter type 9 (GLUT9)	TTIF3GB	GTR9_HUMAN	Inhibitor	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT05690204) A Phase 2B Study to Evaluate the Efficacy and Safety in Combination With Standard of Care in Adult Subjects With Gout, and Hyperuricemia Refractory to Conventional XOI Therapy. U.S.National Institutes of Health.
2	Clinical pipeline report, company report or official report of Shanton Pharma Shanghai, China